aTyr Pharma | LIFE - Trade Debtors


aTyr Pharma reported $906K in Trade Debtors for its fiscal quarter ending in March of 2026.





Trade Debtors Change Date
Alterity Therapeutics Limited AUD 4.57M 1.42M Dec/2025
Ardelyx USD 82.84M 10.99M Mar/2026
aTyr Pharma USD 906K 295.84M Mar/2026
Biogen USD 1.79B 76.6M Mar/2026
Bristol-Myers Squibb USD 13.83B 535M Jun/2026
Cipla INR 62.19B 12.42B Mar/2026
Clal Biotechnology ILS 3.75M 186K Dec/2022
Compugen USD 2.34M 44K Mar/2026
CSL USD 4.32B 1.35B Dec/2025
Curis USD 2.55M 400K Jun/2024
GlaxoSmithKline GBP 8.07B 137M Jun/2026
Grifols EUR 1B 285.88M Dec/2025
Lakefront Biotherapeutics EUR 54.03M 145.72M Mar/2026
Novartis USD 9.85B 252M Jun/2026
Roche Holding CHF 13.34B 1.44B Jun/2026
United Therapeutics USD 310.3M 1.7M Jun/2026